ICH E2D

E559691

ICH E2D is an International Council for Harmonisation guideline that provides standards for post-approval safety data management, including the collection, evaluation, and reporting of safety information for marketed medicinal products.

All labels observed (1)

Label Occurrences
ICH E2D canonical 1

How this entity was disambiguated

Statements (48)

Predicate Object
instanceOf ICH guideline ⓘ
pharmacovigilance guideline ⓘ
abbreviationOf International Council for Harmonisation Guideline E2D ⓘ
addresses definitions related to post-approval safety data ⓘ
expedited reporting time frames ⓘ
follow-up of safety reports ⓘ
literature case reporting ⓘ
minimum information for a valid individual case safety report ⓘ
reporting of safety information from compassionate use or named-patient programs ⓘ
reporting of safety information from non-interventional studies ⓘ
reporting of safety information from post-authorization studies ⓘ
reporting of safety information from registries ⓘ
reporting of safety information from special situations such as pregnancy and overdose ⓘ
unlisted and serious adverse reactions ⓘ
appliesTo clinical trial safety reports after marketing authorisation ⓘ
marketed medicinal products ⓘ
post-marketing individual case safety reports ⓘ
spontaneous reports of adverse drug reactions ⓘ
covers company and regulatory responsibilities for safety data management ⓘ
data quality and completeness in safety reports ⓘ
electronic and paper-based safety reporting ⓘ
handling of duplicate reports ⓘ
defines criteria for expedited reporting of individual case safety reports ⓘ
standards for collection of post-marketing safety data ⓘ
standards for evaluation of post-marketing safety data ⓘ
standards for reporting of post-marketing safety data ⓘ
domain drug safety regulation ⓘ
pharmacovigilance ⓘ
focusesOn expedited reporting of safety information ⓘ
post-approval safety data management ⓘ
safety information for marketed medicinal products ⓘ
fullName ICH Harmonised Tripartite Guideline E2D Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting ⓘ
issuedBy International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use ⓘ
objective to harmonise international standards for post-approval safety reporting ⓘ
to improve consistency of expedited safety reporting across regions ⓘ
to support protection of public health through timely safety communication ⓘ
regulatoryRegion European Union ⓘ
ICH regions ⓘ
Japan ⓘ
United States ⓘ
relatedTo ICH E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting ⓘ
ICH E2B Clinical Safety Data Management: Data Elements for Transmission of Individual Case Safety Reports ⓘ
ICH E2C Periodic Benefit-Risk Evaluation Report (PBRER) ⓘ
ICH E2E Pharmacovigilance Planning ⓘ
status harmonised guideline ⓘ
usedBy marketing authorisation holders ⓘ
pharmaceutical companies ⓘ
regulatory authorities ⓘ

How these facts were elicited

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.